NEW YORK, Feb. 14 (GenomeWeb News) - Berry & Associates has signed a technology licensing deal with Fluorous Technologies for use of its fluorous synthesis and separation technology, the companies said today.
Under the deal, Berry will be able to use the Fluorous Technologies separation technology in a line of fluorous-adapted oligonucleotide synthesis products.
Specific terms of the arrangement were not disclosed.